Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by Gustoeson Aug 23, 2017 1:57pm

155 Views

Post# 26613281

Perspective

https://community.macmillan.org.uk/cancer_types/bladder-cancer/f/14/t/55014

PDT works and bladder cancer patients want it.

In my opinion, Theralase will be the first to solve/complete PDT safety, pre and post care issues and legislation/approvals for mainstream treatment. Phase ii will be a really exciting time, can't wait.

Bullboard Posts

HPQ Silicon updates shareholders on Fumed Silica Reactor developments